Management of Excess Gingival Display Using Tunnel Technique With 3D Designed PEEK Shell: A Case Series (PEEK)

March 19, 2026 updated by: Farah Mamdouh Abdelfatah Mohamed Sheeba, Cairo University
The aim of the current study is to evaluate the use of a PEEK shell placed in the anterior maxilla placed by tunnel technique in decreasing the gingival display

Study Overview

Detailed Description

While lip repositioning has been established as a treatment modality to address excess gum display (EGD) , an often overlooked contributing factor is the lack of lip support. This is often caused by the architecture of the maxilla at the subnasal area. Maxillary overgrowth may give rise to a subnasal skeletal depression producing decreased lip support and marked upper lip retraction during a smile.

Restricting muscle pull by lip repositioning surgery as a treatment option limits muscle movement, however it does not address lip support. In 2018 an alternative intervention was later proposed in a case report study . The technique involves raising a full thickness flap and applying PMMA (polymethyl methacrylate) cement to fill the subnasal depression and limit the upper lip movement. Since its introduction, a limited number of studies have attempted to investigate the technique, however there are not enough studies to support the outcome or the stability of the technique. The aim of the current study is to evaluate the use of a tunnel technique with a 3D printed PEEK (Polyetherether ketone) shell to fill the skeletal subnasal depression

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11835
        • Farah Mamdouh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with excess gingival display 2.5mm or more
  • Patients with an exaggerated subnasal concavity
  • Decreased/normal value of SNA ( angle between sella, nation, A point) in cephalometric measurement
  • Decreased/normal cephalometric measurement of A to N-perpendicular (perpendicular from N on FHP)
  • Decreased/normal value in cephalometric measurement of the convexity at point A (linear measurement from point A to facial plane)
  • Decreased/normal value of Ricketts Esthetic plane in cephalometric measurement
  • Decreased/normal value of Holdaway H-angle in cephalometric measurement
  • Nasolabial angle range from 100° to 120°
  • Patients 20-60 years old
  • Medically free
  • Compliant patient that agrees to the follow up period

Exclusion Criteria:

  • Pregnant and lactating females
  • Smokers
  • Diabetics
  • Patients with parafunctional habits that may affect the outcome of the procedure
  • Medically compromised patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PEEK shell in the anterior maxilla inserted by tunnel technique
use of a minimally invasive tunnel technique to fill the skeletal subnasal depression with a PEEK shell in patients with an exaggerated subnasal depression associated with lack of lip support and excessive lip translation

The area will be anesthetized using infiltration technique with 1.5ml of anesthetic solution containing Articaine Hydrochloride 68 mg/1.7 ml with Adrenaline 0.017 mg/1.7 ml

Two bilateral full thickness vertical incisions will be created using a #15 blade. One on each side of the frenum

A subperiosteal tunnel connecting the two vertical incisions will be created using a periosteal elevator/tunneling knife until the complete communication between the two ends is established

The custom made PEEK framework will be inserted from the incision on one side and eased through until it sits in the subnasal concavity.

Once fitted in place the shell will be fixed in place using two mini screws bilaterally, one on each side.

The two vertical incisions will be closed by interrupted sutures 6-0 Polyglycolic acid suture material

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gingival display
Time Frame: Day 0 - Month 3 - Month 6
measured using a periodontal probe in millimeters
Day 0 - Month 3 - Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
lip translation
Time Frame: Day 0 - Month 3 - Month 6
measured using a periodontal probe in millimeters
Day 0 - Month 3 - Month 6
profile angle
Time Frame: Day 0 - Month 6
lateral cephalometric xray
Day 0 - Month 6
lip length
Time Frame: Day 0 - Month 3 - Month 6
measured using a periodontal probe in millimeters
Day 0 - Month 3 - Month 6
patient satisfaction
Time Frame: Day 7
measured by a binary Questionnaire ( yes or no)
Day 7
Post operative pain
Time Frame: Day 7
Measured by the visual analogue scale ( 0 no pain, 10 worst pain)
Day 7
blinded esthetic assessment
Time Frame: Month 3- Month 6
measured by a binary scale (yes or no)
Month 3- Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 8, 2023

Primary Completion (Actual)

January 7, 2026

Study Completion (Actual)

January 7, 2026

Study Registration Dates

First Submitted

August 17, 2023

First Submitted That Met QC Criteria

August 28, 2023

First Posted (Actual)

August 30, 2023

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 21623 (City of Hope Medical Center)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

2025

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Excessive Gingival Display

Subscribe